Efficacy of Fixed Low-Dose Weekly Subcutaneous Testosterone Self-Administration in Transgender Male Patients in India
Indian Journal of Endocrinology and Metabolism · 2026-03 · 30 (2) · 164-169
DOI: 10.4103/ijem.ijem_926_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Endocrinology and Metabolism, online erschienen am 30.04.2026. Verfasst von Debmalya Sanyal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, KPC Medical College and Hospital, Kolkata, West Bengal, India. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Testosterone (T) is commonly administered intramuscularly to treat hypogonadal males and female-to-male (FTM) transgender patients. Intramuscular testosterone administration has various drawbacks, including discomfort, bruising, pain, and the need to be administered by a healthcare professional. Self-administered subcutaneous route may be a convenient, safe, and effective alternative. The current study assesses the efficacy and safety of low-dose (50 mg) weekly subcutaneous testosterone administration among FTM transgender.
Methods
The current retrospective cohort study included adult FTM transgender subjects. Participants were administered T-cypionate weekly at a dose of 50 mg and followed up for 6 months. At the end of the follow-up, serum concentrations of testosterone, oestradiol (E2), and the number of participants achieving target E2 (300 ng/mL) in 81% and 68% of subjects, respectively. Ninety-one per cent of subjects had cessation of menstruation. No subject needed to stop testosterone injections or decrease dosage due to polycythaemia (PCV > 50%).
Conclusion
Weekly self-administered 50 mg low-dose, subcutaneous testosterone injection was effective in achieving target testosterone and oestradiol levels in FTM transgender subjects, without significant safety issues.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, KPC Medical College and Hospital, Kolkata, West Bengal, India.
- Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Kalyani, West Bengal, India.
- Department of Medicine, Endocrinology, Diabetes and Metabolism, University of Colorado School of Medicine, Aurora, CO, United States of America.
Zitieren
APA
Sanyal, D., Patra, S., & Rothman, M. S. (2026). Efficacy of Fixed Low-Dose Weekly Subcutaneous Testosterone Self-Administration in Transgender Male Patients in India. Indian Journal of Endocrinology and Metabolism, 30(2), 164-169. https://doi.org/10.4103/ijem.ijem_926_25
Vancouver
Sanyal D, Patra S, Rothman MS. Efficacy of Fixed Low-Dose Weekly Subcutaneous Testosterone Self-Administration in Transgender Male Patients in India. Indian Journal of Endocrinology and Metabolism. 2026;30(2):164-169. doi:10.4103/ijem.ijem_926_25
BibTeX
@article{Sanyal2026,
author = {Sanyal, Debmalya and Patra, Shinjan and Rothman, Micol S},
title = {Efficacy of Fixed Low-Dose Weekly Subcutaneous Testosterone Self-Administration in Transgender Male Patients in India},
journal = {Indian Journal of Endocrinology and Metabolism},
year = {2026},
volume = {30},
number = {2},
pages = {164--169},
doi = {10.4103/ijem.ijem_926_25}
}
EUVIMED